個案總覽

Qualtrics was an online survey research platform and since the beginning, the company had relied entirely on an inside sales model-sales done remotely without face-to-face contact with clients. The low-cost inside sales model, along with an emphasis on a strong sales culture, had helped Qualtrics to grow rapidly. However, it needed to prepare for the next phase of its growth. The company decided to diversify its product portfolio and target different types of customers (enterprise clients). In accordance with this change, it recognized the need to revise the inside-sales-only model by adding a field sales component to better serve these customers. Many organizations often go through a turning point in their strategy to explore ways for growth. The case series outlines the best practices of scaling an inside sales model and the challenges involved in changing an organization's sales management and strategy to initiate future growth.

Supplement to case 418055. In September 2008, Robert Steel presided over the sale of Wachovia, a top U.S. bank, less than three months after becoming its CEO. Wachovia's exposure to risky home loans led depositors and creditors to flee the bank on Friday, September 26, after the FDIC seized and sold a smaller bank with similar exposure, whose collapse nonetheless made it the biggest bank failure in U.S. history. Faced with Wachovia's impending bankruptcy, the FDIC intervened again, voting on Monday, September 29 to sell Wachovia's retail bank to Citigroup for $1 a share. Three days later, Wells Fargo offered $7 a share for all of Wachovia. Steel needed to decide whether to honor the terms of the deal and exclusivity agreement already sketched out with Citigroup or to approve a definitive merger agreement with Wells Fargo.

Supplement to case E562. Between the back half of 2015 and early 2018 CircleUp had both grown and changed substantively. The company's core data and Helio platform had enabled the firm to offer a new set of equity and credit services to startup consumer companies that were too small for traditional private equity but needed growth capital. The transformation of the company was both exciting and a bit unexpected as CEO Ryan Caldbeck navigated the organization through tremendous change and growth.

This case provides a brief overview of the success and challenges of the HNA Group between 2015 and late 2017 when it grew rapidly through global acquisitions to became a Fortune 170 company. How would HNA face the challenges of being a truly global and prominent company in an era of increasing scrutiny of big businesses?

AM-Pharma is a biotech company developing a medicine for patients with acute kidney injury. The case describes the company's journey from inception in 2001 to a large deal with Pfizer in 2015. The aim is to discuss the value creation of AM-Pharma through its strategic decisions over time. It highlights the patient journey, company challenges, market size potential, and how the management team was able to raise multiple financing rounds from venture capitalists. It further provides the readers with a unique insight in the key risks and operational challenges of a biotech company and the value of an experienced management team backed by strong investors. The drug development process is inherently risky, long and expensive and the probability of commercializing a new drug is very low. The company's CEO is the protagonist and the case is split in three parts to provide the readers with surprises and open strategic questions which are time related. The case is semi-chronologically and a patient story is intermingled to provide a different perspective on clinical trials, ethical dilemmas and the high unmet medical need for new therapies. The case ends with a valuation simulation, in which the readers can negotiate the AM-Pharma/Pfizer deal themselves. Learning objective: The aim of the case study is to evaluate the value creation of AM-Pharma strategic decisions over time. 1/ The strategy diamond and Porter's Five Forces will be applied as a tool for understanding the industry and the company's strategy. 2/ The key success factors are also assessed for this challenging setting of a biotech startup. 3/ Role of Serendipity and management vision in opening new doors. 4/ Different exit options are discussed, highlighting pros, cons and what actually happened. 5/ How clinical outcome, and exit timing highly impact the valuation. The case will trigger discussions on the strategic options listed, and engage the students into exit negotiations simulation.

AM-Pharma is a biotech company developing a medicine for patients with acute kidney injury. The case describes the company's journey from inception in 2001 to a large deal with Pfizer in 2015. The aim is to discuss the value creation of AM-Pharma through its strategic decisions over time. It highlights the patient journey, company challenges, market size potential, and how the management team was able to raise multiple financing rounds from venture capitalists. It further provides the readers with a unique insight in the key risks and operational challenges of a biotech company and the value of an experienced management team backed by strong investors. The drug development process is inherently risky, long and expensive and the probability of commercializing a new drug is very low. The company's CEO is the protagonist and the case is split in three parts to provide the readers with surprises and open strategic questions which are time related. The case is semi-chronologically and a patient story is intermingled to provide a different perspective on clinical trials, ethical dilemmas and the high unmet medical need for new therapies. The case ends with a valuation simulation, in which the readers can negotiate the AM-Pharma/Pfizer deal themselves. Learning objective: The aim of the case study is to evaluate the value creation of AM-Pharma strategic decisions over time. 1/ The strategy diamond and Porter's Five Forces will be applied as a tool for understanding the industry and the company's strategy. 2/ The key success factors are also assessed for this challenging setting of a biotech startup. 3/ Role of Serendipity and management vision in opening new doors. 4/ Different exit options are discussed, highlighting pros, cons and what actually happened. 5/ How clinical outcome, and exit timing highly impact the valuation. The case will trigger discussions on the strategic options listed, and engage the students into exit negotiations simulation.

AM-Pharma is a biotech company developing a medicine for patients with acute kidney injury. The case describes the company's journey from inception in 2001 to a large deal with Pfizer in 2015. The aim is to discuss the value creation of AM-Pharma through its strategic decisions over time. It highlights the patient journey, company challenges, market size potential, and how the management team was able to raise multiple financing rounds from venture capitalists. It further provides the readers with a unique insight in the key risks and operational challenges of a biotech company and the value of an experienced management team backed by strong investors. The drug development process is inherently risky, long and expensive and the probability of commercializing a new drug is very low. The company's CEO is the protagonist and the case is split in three parts to provide the readers with surprises and open strategic questions which are time related. The case is semi-chronologically and a patient story is intermingled to provide a different perspective on clinical trials, ethical dilemmas and the high unmet medical need for new therapies. The case ends with a valuation simulation, in which the readers can negotiate the AM-Pharma/Pfizer deal themselves. Learning objective: The aim of the case study is to evaluate the value creation of AM-Pharma strategic decisions over time. 1/ The strategy diamond and Porter's Five Forces will be applied as a tool for understanding the industry and the company's strategy. 2/ The key success factors are also assessed for this challenging setting of a biotech startup. 3/ Role of Serendipity and management vision in opening new doors. 4/ Different exit options are discussed, highlighting pros, cons and what actually happened. 5/ How clinical outcome, and exit timing highly impact the valuation. The case will trigger discussions on the strategic options listed, and engage the students into exit negotiations simulation.

Supplement to case W18081.

Headquartered in Hangzhou (China), Ant Financial has grown into a fintech "Unicorn." The fintech empire that the company established spanned verticals such as mobile and online payment (Alipay), money market fund (Yu'e Bao), wealth management (Ant Fortune), digital-only banking (MYbank), credit scoring (Zhima Credit ), and consumer credit portal (Ant Credit Pay) among others. After another sales record during the 2016 11.11 Global Shopping Festival along with Alibaba, Long Chen, Chief Strategy Officer of Ant Financial was contemplating the various opportunities and challenges associated with the firm's international expansion, inclusive finance in rural regions, and regulatory uncertainties.

Headquartered in Hangzhou (China), Ant Financial has grown into a fintech "Unicorn." The fintech empire that the company established spanned verticals such as mobile and online payment (Alipay), money market fund (Yu'e Bao), wealth management (Ant Fortune), digital-only banking (MYbank), credit scoring (Zhima Credit ), and consumer credit portal (Ant Credit Pay) among others. After another sales record during the 2016 11.11 Global Shopping Festival along with Alibaba, Long Chen, Chief Strategy Officer of Ant Financial was contemplating the various opportunities and challenges associated with the firm's international expansion, inclusive finance in rural regions, and regulatory uncertainties.

Supplement to case BAB372. Students tend to think they know what a business is - after all, they are avid consumers. This case helps them understand what they do know, and more importantly, what they do not know. The setting is 2009 and is not current, so students must consider whether retail from a process point of view has truly changed, or whether using technology-based interfaces in retail makes it seem to have changed. It also allows students to consider what advances in their retail experiences are the result of technology. The case may be used for class discussion of the following topics. • Foundations of entrepreneurship • What is a business? • Creating financial statements • Analyzing financial statements • Information systems in a business

Students tend to think they know what a business is - after all, they are avid consumers. This case helps them understand what they do know, and more importantly, what they do not know. The setting is 2009 and is not current, so students must consider whether retail from a process point of view has truly changed, or whether using technology-based interfaces in retail makes it seem to have changed. It also allows students to consider what advances in their retail experiences are the result of technology. The case may be used for class discussion of the following topics: Foundations of entrepreneurship; What is a business?; Creating financial statements; Analyzing financial statements; Information systems in a business.

Supplement to BAB387.

Epilogue to case KS1242. In summer and fall of 2014, thousands of individuals in Liberia, Sierra Leone, and Guinea contracted the Ebola virus. This outbreak of the deadly disease, which until then had been highly uncommon in West Africa, prompted a major (albeit delayed) public health response on the part of the international community, including an unprecedented commitment made by the United States, which sent almost 3,000 active military soldiers to Liberia. "Mission in Flux" focuses on the US military's role in the Ebola response, emphasizing the Michigan National Guard's eventual involvement. In particular, it provides readers with a first-hand account of the challenges the Michigan Guard faced as it prepared for and then deployed to Liberia, just as the crisis had begun to abate and federal officials in Washington began considering how to redefine the mission and footprint of Ebola-relief in West Africa. Case number 2107.0

Supplement to case SM299A. In the #MeToo era, allegations of sexual assault and sexual misconduct pose difficult issues for employers, particularly when allegations surface about incidents that occurred prior to an employee's term at the company. This case, fictionalized but based on real events, centers on the challenge that the founder of a biotech company faces when he receives an email alleging that a new employee (male) raped an acquaintance prior to joining his firm. This case brings up questions of how to deal with the person lodging the allegation, the employee concerned, other employees who become aware of the allegation, police, human resources and legal players.

Supplement to case SM299A. In the #MeToo era, allegations of sexual assault and sexual misconduct pose difficult issues for employers, particularly when allegations surface about incidents that occurred prior to an employee's term at the company. This case, fictionalized but based on real events, centers on the challenge that the founder of a biotech company faces when he receives an email alleging that a new employee (male) raped an acquaintance prior to joining his firm. This case brings up questions of how to deal with the person lodging the allegation, the employee concerned, other employees who become aware of the allegation, police, human resources and legal players.

Supplement to case SM299A. In the #MeToo era, allegations of sexual assault and sexual misconduct pose difficult issues for employers, particularly when allegations surface about incidents that occurred prior to an employee's term at the company. This case, fictionalized but based on real events, centers on the challenge that the founder of a biotech company faces when he receives an email alleging that a new employee (male) raped an acquaintance prior to joining his firm. This case brings up questions of how to deal with the person lodging the allegation, the employee concerned, other employees who become aware of the allegation, police, human resources and legal players.

Two executives at Express Trucking—the vice-president of legal affairs, and the vice-president of sales—were preparing for an executive team meeting. The two vice-presidents were disputing the terms of a customer contract to be signed the following day. According to the vice-president of legal affairs, the contract needed to be revised to include a standard clause regarding Express Trucking’s liability, whereas the vice-president of sales feared losing the contract if any changes were made. The company’s chief executive officer asked the two executives to resolve this dispute before the upcoming executive team meeting. How would the two executives resolve their differences?<br><br> The case involves the students in a role play to develop their competence to address typical conflicts between executive team members, by reproducing the complex environment in which executives operate. Students will be assigned the role of the vice-president of legal affairs (9B18M014); the vice-president of sales (9B18M015); or the observer (9B18M016).

Two executives at Express Trucking—the vice-president of legal affairs, and the vice-president of sales—were preparing for an executive team meeting. The two vice-presidents were disputing the terms of a customer contract to be signed the following day. According to the vice-president of legal affairs, the contract needed to be revised to include a standard clause regarding Express Trucking’s liability, whereas the vice-president of sales feared losing the contract if any changes were made. The company’s chief executive officer asked the two executives to resolve this dispute before the upcoming executive team meeting. How would the two executives resolve their differences?<br><br> The case involves the students in a role play to develop their competence to address typical conflicts between executive team members, by reproducing the complex environment in which executives operate. Students will be assigned the role of the vice-president of legal affairs (9B18M014); the vice-president of sales (9B18M015); or the observer (9B18M016).

This case updates Wenzhou Kangning Hospital Co, Ltd.'s activities since its IPO in late 2015, focusing on its strategy and growth since the IPO and challenges for the future.